许多大型药用担子菌被发现具有抗癌、杀菌、降糖、降血脂等活性,成为药物开发的新潜在资源,深受人们青睐。文中对2010年以来的担子菌新结构活性产物根据活性类型进行综述,特别关注了2014年至今中国作者的研究,重点描述次级代谢产物的结构及生物活性。 Many large-scale medicinal basidiomycetes have been found to have anti-cancer, sterilization, hypoglycemic, hypolipidemic and other activities, as a new potential drug development resources, by the people of all ages. In this paper, the new structures of the active metabolites of Basidiomycetes since 2010 are reviewed according to the type of activity, with particular attention paid to the study of Chinese authors since 2014, focusing on the structure and biological activity of secondary metabolites.